Oasis Management CO Ltd. Finch Therapeutics Group, Inc. Transaction History

Oasis Management CO Ltd.

  • $444 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.91 - $5.11 $429,750 - $1.15 Million
225,000 New
225,000 $639,000

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $563M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Oasis Management CO Ltd. Portfolio

Follow Oasis Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oasis Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Oasis Management CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email